| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 187.13B | 179.09B | 165.56B | 150.72B | 135.56B | 133.35B |
| Gross Profit | 41.46B | 38.71B | 34.40B | 30.29B | 28.49B | 29.62B |
| EBITDA | 15.13B | 13.55B | 12.35B | 10.60B | 9.86B | 12.30B |
| Net Income | 7.43B | 6.85B | 6.88B | 6.25B | 6.24B | 6.54B |
Balance Sheet | ||||||
| Total Assets | 192.33B | 196.78B | 168.84B | 142.69B | 133.06B | 131.19B |
| Cash, Cash Equivalents and Short-Term Investments | 72.81B | 36.28B | 14.88B | 11.72B | 21.29B | 18.78B |
| Total Debt | 40.91B | 40.42B | 27.01B | 14.40B | 12.41B | 11.68B |
| Total Liabilities | 110.02B | 111.43B | 93.17B | 76.05B | 73.51B | 77.76B |
| Stockholders Equity | 78.18B | 81.30B | 72.93B | 65.19B | 59.25B | 53.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.54B | -6.40B | -5.37B | 5.43B | 9.67B |
| Operating Cash Flow | 0.00 | 13.32B | -5.49B | -4.34B | 6.63B | 10.40B |
| Investing Cash Flow | 0.00 | -3.33B | -2.34B | -5.62B | -3.33B | -3.25B |
| Financing Cash Flow | 0.00 | 11.25B | 10.58B | -113.00M | -1.15B | -2.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥127.48B | 21.86 | 12.54% | 1.84% | 13.86% | 51.05% | |
72 Outperform | ¥862.40B | 16.97 | 6.61% | 1.58% | 5.02% | -27.41% | |
72 Outperform | ¥73.12B | 11.99 | 16.37% | 2.79% | 31.48% | 16.11% | |
69 Neutral | ¥220.21B | 10.37 | 9.02% | 3.11% | 1.25% | -3.97% | |
68 Neutral | ¥681.68B | 23.01 | ― | 1.43% | 7.87% | 38.32% | |
66 Neutral | ¥174.43B | -49.70 | ― | 2.41% | 2.47% | 1.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |